Carlo Leonetti

7.0k citations

129 papers · 5.1k indexed · h-index 41

Impact in

Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Molecular Biology top 2%
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- DNA Repair Mechanisms

Papers in

Oncology 57
- PARP inhibition in cancer therapy 13
- Cancer-related Molecular Pathways 8
- Bone health and treatments 8
Molecular Biology 85
- RNA Interference and Gene Delivery 27
- DNA and Nucleic Acid Chemistry 26
- Advanced biosensing and bioanalysis techniques 25
- Cancer therapeutics and mechanisms 14

Co-authors: Annamaria Biroccio Gabriella Zupi Manuela Porru Marco Scarsella Angela Rizzo Lucio Tentori Antonella Stoppacciaro Erica Salvati
Journals: Journal of Experimental & Clinical Cancer Research (11 papers)European Journal of Cancer (6 papers)International Journal of Cancer (5 papers)Nucleic Acids Research (4 papers)Oncogene (4 papers)
Partner nations: Italy United States Malaysia

In The Last Decade

Carlo Leonetti

129 papers receiving 4.9k citations

Peers

Countries citing papers authored by Carlo Leonetti

Since Specialization

Citations

This map shows the geographic impact of Carlo Leonetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Leonetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Leonetti more than expected).

Fields of papers citing papers by Carlo Leonetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Leonetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Leonetti. The network helps show where Carlo Leonetti may publish in the future.

Co-authors

The 25 scholars most cited alongside Carlo Leonetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlo Leonetti Line = papers co-authored together Carlo Leonetti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use International Journal of Molecular Sciences ·Marianna Abate, Kathleen Bao, Valeria Nele, Michele Caraglia, Marco Biondi, Giuseppe De Rosa, Carlo Leonetti, Virginia Campani, Silvia Zappavigna, Manuela Porru	2022	5
2	Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer Molecular Cancer Therapeutics ·Manuela Porru, Simona Artuso, Erica Salvati, Armandodoriano Bianco, Marco Franceschin, Maria Grazia Diodoro, Daniela Passeri, Augusto Orlandi, Francesco Savorani, Maurizio D’Incalci, Annamaria Biroccio, Carlo Leonetti	2015	25
3	Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models PLoS ONE ·Anna Tesei, Carlo Leonetti, Marzia Di Donato, Pingman Zhang, Manuela Porru, Greta Varchi, Andrea Guerrini, Dino Amadori, Chiara Arienti, Sara Pignatta, C Karthikeyan, Michele Caraglia, Gabriella Castoria, Wainer Zoli	2013	15
4	DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents Clinical Cancer Research ·Annamaria Biroccio, Manuela Porru, Angela Rizzo, Erica Salvati, Carmen D’Angelo, Augusto Orlandi, Daniela Passeri, Marco Franceschin, Malcolm F. G. Stevens, Éric Gilson, Giovanni Luca Beretta, Gabriella Zupi, Claudio Pisano, Franco Zunino, Carlo Leonetti	2011	29
5	Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment Reumatismo ·Lúcio Mauro Estolano de Matos, Rosario Foti, Robert A. Leonardi, Carlo Leonetti, Pietro Castellino	2011	1
6	Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs Cell Cycle ·Rosa Puca, Lavinia Nardinocchi, Manuela Porru, Anthony Simon, Gideon Rechavi, Carlo Leonetti, David Givol, Gabriella D’Orazi	2011	100
7	Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study Molecular Cancer ·Paola Matarrese, Barbara Ascione, Laura Ciarlo, Rosa Vona, Carlo Leonetti, Marco Scarsella, Anna Maria Mileo, Caterina Catricalà, Marco G. Paggi, Walter Malorni	2010	85
8	Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown Cancer Research ·Rosa Puca, Lavinia Nardinocchi, Hilah Gal, Gideon Rechavi, Ninette Amariglio, Eytan Domany, Daniel A. Notterman, Marco Scarsella, Carlo Leonetti, Ada Sacchi, Giovanni Blandino, David Givol, Gabriella D’Orazi	2008	62
9	NCX 4040, an NO-donating acetylsalicylic acid derivative: Efficacy and mechanisms of action in cancer cells Nitric Oxide ·Anna Tesei, Wainer Zoli, Francesco� Fabbri, Carlo Leonetti, Marco Rosetti, Manlio Bolla, Dino Amadori, Rosella Silvestrini	2008	23
10	Scleroderma-like disorders Autoimmunity Reviews ·حر فلاح, Rosario Leonardi, R Rondinone, Lúcio Mauro Estolano de Matos, Carlo Leonetti, M Canova, Andrea Doria	2008	40
11	RHPS4 telomere-interactive molecule: an active antitumoral agent with a high therapeutic index and a favorable integration with camptothecin in preclinical models of solid tumors Molecular Cancer Therapeutics ·Carlo Leonetti, Marco Scarsella, Angela Rizzo, Erica Salvati, Maurizio D’Incalci, Malcolm F. G. Stevens, Antonella Stoppacciaro, Éric Gilson, Gabriella Zupi, Annamaria Biroccio	2007	1
12	TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells European Journal of Cancer ·Annamaria Biroccio, Angela Rizzo, R. Elli, Chen Jyh-Yih, M. Friedl, Barbara Benassi, Carlo Leonetti, Malcolm F. G. Stevens, Maurizio D’Incalci, Gabriella Zupi, Éric Gilson	2006	55
13	In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines Journal of Translational Medicine ·Anna Tesei, Paola Ulivi, Francesco� Fabbri, Marco Rosetti, Carlo Leonetti, Marco Scarsella, Gabriella Zupi, Dino Amadori, Manlio Bolla, Wainer Zoli	2005	28
14	Lonidamine Causes Inhibition of Angiogenesis-Related Endothelial Cell Functions Neoplasia ·Donatella Del Bufalo, Daniela Trisciuoglio, Marco Scarsella, Giulia d’Amati, Antonio Candiloro, Angela Iervolino, Carlo Leonetti, Gabriella Zupi	2004	27
15	Antisense oligodeoxynucleotides for urokinase‐plasminogen activator receptor have anti‐invasive and anti‐proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice International Journal of Cancer ·Silvia D’Alessio, Francesca Margheri, Marco Pucci, Angela Del Rosso, Brett P. Monia, Mauro Bologna, Carlo Leonetti, Marco Scarsella, Gabriella Zupi, Gabriella Fibbi, Mario Del Rosso	2004	33
16	In Vitro and in Vivo Inhibition of SK-N-MC Neuroblastoma Growth Using Cyclic nucleotide Phosphodiesterase Inhibitors Journal of Neuro-Oncology ·Mauro Giorgi, Carlo Leonetti, Gennaro Citro, Gabriella Augusti‐Tocco	2001	4
17	Enhanced Anti-Tumor Effects with Microencapsulated c- myc Antisense Oligonucleotide Antisense and Nucleic Acid Drug Development ·Scott D. Putney, Josiah Brown, C Cucco, 何海玉, Tomasz Skórski, Carlo Leonetti, HERSCHEL C. GORE, Bruno Calabretta, Gabriella Zupi, Gerald Zon	1999	32
18	Different effects of sequential combinations ofN-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice Journal of Cancer Research and Clinical Oncology ·Giuseppe Arancia, Carlo Leonetti, Walter Malorni, Carla Greco, G. Formisano, M. Marangolo, Gabriella Zupi	1991	10
19	IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3′ dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro International Journal of Immunopharmacology ·Lucio Tentori, Carlo Leonetti, Giulia Lanzilli, Enzo Bonmassar	1990	8
20	Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line British Journal of Cancer ·Elbert Nevius Sebring Thompson, Gabriella Zupi, Eugenio Erba, Carlo Leonetti, Maurizio D’Incalci	1990	7

About Carlo Leonetti

Carlo Leonetti is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Allergy and Biotechnology, having authored 129 papers that have together received 5.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (27 papers), DNA and Nucleic Acid Chemistry (26 papers), Advanced biosensing and bioanalysis techniques (25 papers), Cancer therapeutics and mechanisms (14 papers), PARP inhibition in cancer therapy (13 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Cancer-related Molecular Pathways (8 papers) and Bone health and treatments (8 papers). The work is most often cited by research in Oncology (1.8k citations), Molecular Biology (3.2k citations), Cancer Research (684 citations), Genetics (262 citations) and Aging (40 citations). Carlo Leonetti has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Annamaria Biroccio, Gabriella Zupi, Manuela Porru, Marco Scarsella, Angela Rizzo, Lucio Tentori, Antonella Stoppacciaro, Erica Salvati, Grazia Graziani and Donatella Del Bufalo. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, European Journal of Cancer, International Journal of Cancer, Nucleic Acids Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact